共 50 条
Measurement and Mitigation of Bias in Artificial Intelligence: A Narrative Literature Review for Regulatory Science
被引:6
|作者:
Gray, Magnus
[1
]
Samala, Ravi
[2
]
Liu, Qi
[3
]
Skiles, Denny
[4
]
Xu, Joshua
[1
]
Tong, Weida
[1
]
Wu, Leihong
[1
]
机构:
[1] US FDA, Div Bioinformat & Biostat, Natl Ctr Toxicol Res, Jefferson, AR 72079 USA
[2] US FDA, Div Imaging Diagnost & Software Reliabil, Off Sci & Engn Labs, Ctr Devices & Radiol Hlth, Silver Spring, MD USA
[3] US FDA, Off Clin Pharmacol, Off Translat Sci, Ctr Drug Evaluat & Res, Silver Spring, MD USA
[4] US FDA, Off Management, Natl Ctr Toxicol Res, Jefferson, AR USA
关键词:
D O I:
10.1002/cpt.3117
中图分类号:
R9 [药学];
学科分类号:
1007 ;
摘要:
Artificial intelligence (AI) is increasingly being used in decision making across various industries, including the public health arena. Bias in any decision-making process can significantly skew outcomes, and AI systems have been shown to exhibit biases at times. The potential for AI systems to perpetuate and even amplify biases is a growing concern. Bias, as used in this paper, refers to the tendency toward a particular characteristic or behavior, and thus, a biased AI system is one that shows biased associations entities. In this literature review, we examine the current state of research on AI bias, including its sources, as well as the methods for measuring, benchmarking, and mitigating it. We also examine the biases and methods of mitigation specifically relevant to the healthcare field and offer a perspective on bias measurement and mitigation in regulatory science decision making.
引用
收藏
页码:687 / 697
页数:11
相关论文